This is an audio transcript of the Life and Art from FT Weekend podcast episode: ‘Fashion loves Ozempic. Should we talk about it?’ ...

New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.

India’s powerful copycat pharmaceutical industry is set to roll out generic weight-loss drugs in the UK within weeks, with one leading producer forecasting a “huge price war t ...

A new CDC report reveals that over 15.5 million U.S. adults have ADHD, with 71.5 per cent facing difficulties obtaining ...

I don’t normally pay much attention to the world of high fashion, but the controversy sparked by last month’s Paris fashion ...

The future of the weight loss market might not revolve around GLP-1 drugs.

L.A. is particularly susceptible to “miracle” cures. And there are some troubling aspects of the Ozempic gold rush that don’t ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

In the ever-changing healthcare landscape, it is crucial to develop sustainable long-term strategies that look beyond ...

In a year and a half, Eli Lilly (NYSE: LLY) has roughly doubled in value. It is now the most valuable pharmaceutical company ...

Medics have shared a cautionary tale, based on real stories of patients they have seen, of a women who fell into a trap posed ...